MXPA03002954A - Uso de antiprogestinas para profilaxis y tratamiento de enfermedades dependientes de las hormonas. - Google Patents

Uso de antiprogestinas para profilaxis y tratamiento de enfermedades dependientes de las hormonas.

Info

Publication number: MXPA03002954A
Authority: MX; Mexico
Prior art keywords: antiprogestins; hormone; prophylaxis; treatment; dependent diseases
Prior art date: 2000-10-18

Application number

MXPA03002954A

Other languages

English (en)

Inventor

Rosemarie Lichtner

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-18

Filing date

2001-10-17

Publication date

2003-08-07

2001-10-17 Application filed by Schering Ag filed Critical Schering Ag

2003-08-07 Publication of MXPA03002954A publication Critical patent/MXPA03002954A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MXPA03002954A 2000-10-18 2001-10-17 Uso de antiprogestinas para profilaxis y tratamiento de enfermedades dependientes de las hormonas. MXPA03002954A (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24099800P	2000-10-18	2000-10-18
EP00250341		2000-10-18
PCT/EP2001/012005 WO2002032430A1 (en)	2000-10-18	2001-10-17	Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Publications (1)

Publication Number	Publication Date
MXPA03002954A true MXPA03002954A (es)	2003-08-07

Family

ID=26072951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03002954A MXPA03002954A (es)	2000-10-18	2001-10-17	Uso de antiprogestinas para profilaxis y tratamiento de enfermedades dependientes de las hormonas.

Country Status (26)

Country	Link
US (1)	US7378406B2 (es)
EP (1)	EP1328276B1 (es)
JP (2)	JP2004511522A (es)
KR (1)	KR100632908B1 (es)
CN (1)	CN1512886A (es)
AT (1)	ATE310522T1 (es)
AU (2)	AU1824302A (es)
BG (1)	BG107743A (es)
BR (1)	BR0114665A (es)
CA (1)	CA2423017C (es)
CY (1)	CY1104981T1 (es)
CZ (1)	CZ299942B6 (es)
DE (1)	DE60115274T2 (es)
DK (1)	DK1328276T3 (es)
EE (1)	EE05259B1 (es)
ES (1)	ES2253443T3 (es)
HR (1)	HRP20030387A2 (es)
HU (1)	HUP0301460A3 (es)
IL (2)	IL154975A0 (es)
MX (1)	MXPA03002954A (es)
NO (1)	NO20031740L (es)
NZ (1)	NZ538346A (es)
PL (1)	PL360151A1 (es)
SI (1)	SI1328276T1 (es)
SK (1)	SK287124B6 (es)
WO (1)	WO2002032430A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY27301A1 (es) *	2001-05-25	2003-02-28	Schering Ag	Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
DE10159217A1 (de)	2001-11-27	2003-06-05	Schering Ag	17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) *	2003-05-28	2004-12-02	Schering Ag	Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US9517240B2 (en) *	2006-09-26	2016-12-13	The Regents Of The University Of California	Methods and compositions for cancer prevention and treatment
EP2136796A2 (en) *	2007-04-23	2009-12-30	Bayer Schering Pharma Aktiengesellschaft	Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
US20080261929A1 (en) *	2007-04-23	2008-10-23	Jens Hoffmann	Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
US20080268041A1 (en) *	2007-04-23	2008-10-30	Jens Hoffmann	Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
TWI477276B (zh) *	2008-04-28	2015-03-21	Repros Therapeutics Inc	抗黃體素給藥方案
TWI539953B (zh) *	2008-04-28	2016-07-01	瑞波若斯治療學公司	用於治療乳癌之組成物和方法
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de)	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
US20130018027A1 (en) *	2010-03-22	2013-01-17	Repros Therapeutics Inc.	Compositions and methods for non-toxic delivery of antiprogestins
SG11201407397WA (en)	2012-05-31	2014-12-30	Repros Therapeutics Inc	Formulations and methods for vaginal delivery of antiprogestins
JP6343619B2 (ja)	2012-11-02	2018-06-13	レプロスセラピューティクスインコーポレイティド	プロゲステロン依存性病態を処置する方法およびその組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3733478A1 (de) *	1987-10-01	1989-04-13	Schering Ag	Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE19706061A1 (de)	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

2001
- 2001-10-17 IL IL15497501A patent/IL154975A0/xx active IP Right Grant
- 2001-10-17 MX MXPA03002954A patent/MXPA03002954A/es active IP Right Grant
- 2001-10-17 JP JP2002535668A patent/JP2004511522A/ja not_active Ceased
- 2001-10-17 NZ NZ538346A patent/NZ538346A/en unknown
- 2001-10-17 AU AU1824302A patent/AU1824302A/xx active Pending
- 2001-10-17 WO PCT/EP2001/012005 patent/WO2002032430A1/en not_active Ceased
- 2001-10-17 CZ CZ20031072A patent/CZ299942B6/cs not_active IP Right Cessation
- 2001-10-17 DK DK01987668T patent/DK1328276T3/da active
- 2001-10-17 PL PL36015101A patent/PL360151A1/xx not_active Application Discontinuation
- 2001-10-17 AU AU2002218243A patent/AU2002218243B2/en not_active Ceased
- 2001-10-17 DE DE60115274T patent/DE60115274T2/de not_active Expired - Lifetime
- 2001-10-17 CN CNA018175686A patent/CN1512886A/zh active Pending
- 2001-10-17 BR BR0114665-3A patent/BR0114665A/pt not_active Application Discontinuation
- 2001-10-17 ES ES01987668T patent/ES2253443T3/es not_active Expired - Lifetime
- 2001-10-17 HR HR20030387A patent/HRP20030387A2/xx not_active Application Discontinuation
- 2001-10-17 EP EP01987668A patent/EP1328276B1/en not_active Expired - Lifetime
- 2001-10-17 SI SI200130486T patent/SI1328276T1/sl unknown
- 2001-10-17 US US10/399,320 patent/US7378406B2/en not_active Expired - Fee Related
- 2001-10-17 CA CA002423017A patent/CA2423017C/en not_active Expired - Fee Related
- 2001-10-17 SK SK474-2003A patent/SK287124B6/sk not_active IP Right Cessation
- 2001-10-17 AT AT01987668T patent/ATE310522T1/de not_active IP Right Cessation
- 2001-10-17 HU HU0301460A patent/HUP0301460A3/hu unknown
- 2001-10-17 KR KR1020037005359A patent/KR100632908B1/ko not_active Expired - Fee Related
- 2001-10-17 EE EEP200300155A patent/EE05259B1/xx not_active IP Right Cessation
2003
- 2003-03-18 IL IL154975A patent/IL154975A/en not_active IP Right Cessation
- 2003-04-15 NO NO20031740A patent/NO20031740L/no not_active Application Discontinuation
- 2003-04-18 BG BG107743A patent/BG107743A/bg unknown
2006
- 2006-02-22 CY CY20061100251T patent/CY1104981T1/el unknown
2009
- 2009-12-16 JP JP2009284779A patent/JP2010077158A/ja not_active Ceased

Also Published As

Publication number	Publication date
CY1104981T1 (el)	2010-03-03
SI1328276T1 (sl)	2006-04-30
CN1512886A (zh)	2004-07-14
ATE310522T1 (de)	2005-12-15
IL154975A0 (en)	2003-10-31
SK4742003A3 (en)	2004-09-08
IL154975A (en)	2007-05-15
CA2423017C (en)	2009-01-06
EE200300155A (et)	2003-08-15
SK287124B6 (sk)	2009-12-07
NO20031740D0 (no)	2003-04-15
KR20030044007A (ko)	2003-06-02
EP1328276A1 (en)	2003-07-23
HRP20030387A2 (en)	2005-04-30
CZ299942B6 (cs)	2008-12-29
AU2002218243B2 (en)	2006-07-13
US20040048841A1 (en)	2004-03-11
HUP0301460A3 (en)	2010-01-28
DE60115274D1 (de)	2005-12-29
NZ538346A (en)	2007-03-30
EP1328276B1 (en)	2005-11-23
NO20031740L (no)	2003-06-17
CA2423017A1 (en)	2002-04-25
WO2002032430A1 (en)	2002-04-25
KR100632908B1 (ko)	2006-10-13
US7378406B2 (en)	2008-05-27
BG107743A (bg)	2004-01-30
BR0114665A (pt)	2004-01-13
DE60115274T2 (de)	2006-07-27
JP2004511522A (ja)	2004-04-15
JP2010077158A (ja)	2010-04-08
DK1328276T3 (da)	2006-04-03
HUP0301460A2 (hu)	2003-10-28
PL360151A1 (en)	2004-09-06
EE05259B1 (et)	2010-02-15
ES2253443T3 (es)	2006-06-01
AU1824302A (en)	2002-04-29

Publication	Publication Date	Title
AU1824302A (en)	2002-04-29	Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
AU3846901A (en)	2001-08-27	Oral, nasal and pulmonary dosage formualtions of copolymer 1
EA200301022A1 (ru)	2004-02-26	Гормональная заместительная терапия
MXPA05012841A (es)	2006-02-13	Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas.
YU30103A (sh)	2006-08-17	Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
EE200300157A (et)	2003-08-15	Antiprogestiinide kasutamine apoptoosi esilekutsumiseks rakus
MXPA02011533A (es)	2003-04-25	Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
TW200733955A (en)	2007-09-16	Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
YU29903A (sh)	2006-08-17	Upotreba antiprogestina za indukciju apoptoze u ćeliji
UY27301A1 (es)	2003-02-28	Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata

Legal Events

Date	Code	Title	Description
2007-12-04	FG	Grant or registration